west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "胡时栋" 2 results
  • Effect of Application of Thymopentin during Perioperative Period on Immune Function of Patients Undergoing Laparoscopic Assisted Radical Resection for Rectal Carcinoma

    ObjectiveTo investigate effect of application of thymopentin during perioperative period on immune function of patients undergoing laparoscopic assisted radical resection for rectal carcinoma. MethodsForty-two patients undergoing laparoscopic assisted radical resection for rectal carcinoma from January 2015 to April 2015 in this hospital were collected. These patients were divided into study group and control group. The patients were received routine treatment in the control group. In addition to routine treatment same as the control group, the patients were received 2 mg thymopentin every day for a week in the study group. The changes of lymphocyte count, T lymphocyte subsets (CD3+, CD4+, CD8+, and CD4+/CD8+), and immunoglobulin (IgG, IgA, and IgM) were compared on the 1st day before surgery and on the 1st day and 5th day after surgery. ResultsThe lymphocyte count, T lymphocyte subsets, and immunoglobulin on the first day after surgery were significantly lower than those on the 1st day before surgery in these two groups (P < 0.05). The lymphocyte count, T lymphocyte subsets (except for CD4+/CD8+), and immunoglobulin (except for IgA) in the study group were significantly higher than those in the control group on the 5th day after surgery (P < 0.05). The changes of lymphocyte count, T lymphocyte subsets, and immunoglobulin in the study group had no significant differences between on the 5th day after surgery and on the 1st day before surgery (P > 0.05), but which on the 5th day afer surgery were significantly lower than those on the 1st day before surgery (P < 0.05) in the control group. ConclusionApplication of thymopentin during perioperative period could accelerate recovery of immune function after operation in patients undergoing laparoscopic assisted radical resection for rectal carcinoma.

    Release date: Export PDF Favorites Scan
  • TSA-DC-CTL 细胞免疫治疗联合 PD-L1 抗体治疗高龄晚期结肠癌 1 例报道并文献复习

    目的报道 1 例肿瘤特异性抗原(TSA)刺激诱导树突状细胞(DC)及细胞毒性 T 淋巴细胞(CTL)过继治疗联合程序性死亡配体 1(PD-L1)抗体治疗高龄晚期结肠癌患者。方法2018 年 2 月笔者所在医院对 1 例 90 岁高龄女性患者因“回盲部癌伴梗阻”行剖腹探查、回盲部切除、小肠部分切除、末端回肠造瘘、腹膜活检术,肿瘤广泛转移,患者基础条件差,术后无法耐受常规治疗。经与患者家属充分沟通知情同意及解放军总医院伦理委员会批准,于术后 4 个月开始行 4 次 TSA-DC 细胞皮内多点注射,4 次 TSA-CTL 细胞静脉滴注,2 次 TSA-CTL 细胞腹腔注入,1 次 PD-L1 抗体 1 200 mg 静脉滴注。结果行 TSA-DC-CTL 联合 PD-L1 治疗后 7 d(治疗中期),患者的 KPS 评分升至 80 分(治疗前 40 分),外周血循环肿瘤细胞计数降至 7 个/3.2 mL(治疗前 16 个/3.2 mL),肿瘤标志物 CA125 降至 155.5 u/mL(治疗前 224.4 u/mL),治疗过程中未见相关不良反应。行 TSA-DC-CTL 联合 PD-L1 治疗后 36 d 患者突然出现血压和血氧饱和度下降,给与升压、兴奋呼吸等治疗,情况好转,因家属要求患者自动出院。结论TSA-DC-CTL 细胞免疫治疗联合 PD-L1 治疗本例高龄患者安全可行,能在一定程度上改善患者生活质量及部分生物学指标,但 TSA-DC-CTL 联合 PD-L1 抗体的安全性及近远期疗效有待进一步研究论证。

    Release date:2019-06-05 04:24 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content